Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Radiopharmaceuticals Used in Cardiac Imaging

심장영상에 이용되는 방사성의약품

  • Hwang, Kyung-Hoon (Departments of Nuclear Medicine, Gachon University Gil Hospital) ;
  • Chung, Yong-An (Department of Radiology, Incheon St. Mary's Hospital, The Catholic University of Korea) ;
  • Lee, Byeong-Il (Chonnam National University Hwasun Hospital) ;
  • Lee, Yu-Kyung (Departments of Nuclear Medicine, Gachon University Gil Hospital) ;
  • Lee, Min-Kyung (Departments of Nuclear Medicine, Gachon University Gil Hospital) ;
  • Choe, Won-Sick (Departments of Nuclear Medicine, Gachon University Gil Hospital)
  • 황경훈 (가천의과학대학교 길병원 핵의학과) ;
  • 정용안 (카톨릭대학교 인천성모병원 영상의학과) ;
  • 이병일 (전남대학교 화순병원 핵의학과) ;
  • 이유경 (가천의과학대학교 길병원 핵의학과) ;
  • 이민경 (가천의과학대학교 길병원 핵의학과) ;
  • 최원식 (가천의과학대학교 길병원 핵의학과)
  • Published : 2009.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Many radiopharmaceuticals have been developed and wildy used in the imaging cardiac function. Myocardial perfusion imaging (MPI) is a well established noninvasive method of assessing coronary blood flow and has been widely used in patients diagnosed or suspected with coronary artery diseases. The innovation of radiopharmaceuticals used in the cardiac imaging is one of the most important contributors to the development of nuclear cardiology. Thallium-201 and various technetium-99m agents have been globally used for myocardial perfusion SPEG, and N-13 ammonia (13NH3), rubidium-82 (82Rb), 0-15 water (H2150) for myocardial perfusion PET. As well as the cardiac perfusion studies, new radiopharmaceuticals that visualize fat metabolism or receptors of the sympathetic nervous system have successfully been applied to clinical practice. Useful information can be obtained for diagnosing coronary artery disease, evaluating patients' condition, or assessing therapeutic effects. In this review, we describe the characteristics and clinical usefulness of radiopharmaceuticals used for cardiac SPEG and PET.

Keywords

References

  1. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion. Circuation 1975;51:641-5 https://doi.org/10.1161/01.CIR.51.4.641
  2. Bradley-Moore PR, Lebowitz E, Greene MW, Atkins HL, Ansari AN. Thallium-201 for medical use. II. Biologic behavior. J Nucl Med 1975;16:156-60
  3. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cordiol 1983; 1:994-1001 https://doi.org/10.1016/S0735-1097(83)80100-4
  4. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamolethallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389-94 https://doi.org/10.1056/NEJM198502143120701
  5. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cordiol 1998;32:57-62 https://doi.org/10.1016/S0735-1097(98)00177-6
  6. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circuation 1998;97:535-43 https://doi.org/10.1161/01.CIR.97.6.535
  7. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circuation 1983;68:321-36 https://doi.org/10.1161/01.CIR.68.2.321
  8. Sapirstein LA. Regional blood flow by fractional distribution of indicators. Am J Physiol 1958;193:161-6
  9. McCall D, Zimmer LJ, Katz AM. Kinetics of thallium exchange in cultured rabbit myocardial cells. Circ Res 1985;56:370-6 https://doi.org/10.1161/01.RES.56.3.370
  10. Beller GA, Watson DD, Ackell P, Pohost GM. Time course of thallium-201 redistribution after transient myocardial ischemia. Circuation 1980;61:791-7 https://doi.org/10.1161/01.CIR.61.4.791
  11. Krahwinkel W, Herzog H, Feinendegen LE. Pharmacokinetics of thallium-201 in normal indivisuals after routine myocardial scintigraphy. J Nucl Med 1988;29:1582-6
  12. Jones AG, Davison A, Abram S, Brodack JW, Toothaker AK, Adelstein SJ, et al. Biological studies of a new class of technetium complexes: the hexakis (alkylisonitrile) technetium (I) cations. Int J Nucl Med Biol 1984;11:225-34 https://doi.org/10.1016/0047-0740(84)90004-4
  13. Sinusas AJ, Shi QX, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-71
  14. Younes A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A, et al. Mechanism of uptake of technetium-tetrofosmin. II: uptake into isolated adult rat heart mitochondria J Nucl Cardiol 1995;2:327-33 https://doi.org/10.1016/S1071-3581(05)80077-7
  15. Taillefer R. Technetium-99m-N-NOEt. In: Taillefer R, Tamaki N, eds. New radiotracers in cardiac imaging: principles and applications. Stamford, CT: Appleton Lange, 1999:113-24
  16. Machac J. Cardiac positron emission imaging. Semin Nucl Med 2005;35:17-36 https://doi.org/10.1053/j.semnuclmed.2004.09.002
  17. Lee MC, Chung J-K. Nuclear Cardiology. Seoul: Korea Medical:2003
  18. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N, et al. Metabolism and kinetics of iodine-123 BMIPP in canine myocardium. J Nucl Med 1996;37:757-61
  19. Noriyasu K, Mabuchi M, Kuge Y, Morita K, Tsukamoto T, Kohya T, et al. Serial changes in BMIPP uptake in relation to thallium in the rat myocardium after ischemia. Eur J Nucl Med Mol Imaging 2003;30:1644-50 https://doi.org/10.1007/s00259-003-1305-z
  20. Alman KC, Lahiri A. I-123 MIBG scintigraphy in idiopathic dilated cardiomyopathy: where next? J Nucl Cardiol 2002;9:127-30 https://doi.org/10.1067/mnc.2002.121175
  21. Momose M, Kobayashi H, Iguchi N, Matsuda N, Sakomura Y, Kasanuki H, et al. Comparison of parameters of I-123 MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl Med Commun 1999;20:529-35 https://doi.org/10.1097/00006231-199906000-00007